Protalix and Pfizer’s Gaucher drug Elelyso receives FDA approval

The FDA approved Protalix BioTherapeutics and Pfizer's injectable drug Elelyso to treat patients with type 1 Gaucher disease. -More- …
Read the full story: BIO SmartBrief